Dermata Therapeutics Inc. (DRMA)
Market Open
15 Dec, 20:21
NASDAQ (CM) NASDAQ (CM) Primary $
2. 48
-0.15
-5.7%
$
2.07M Market Cap
- P/E Ratio
0% Div Yield
46,405 Volume
-1.38 Eps
$ 2.63
Previous Close Day Range
2.48 2.71
Year Range
2.34 23.7
Want to track DRMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| DRMA Dermata Therapeutics Inc. 18 Nov 2025 | | - | - |
| DRMA Dermata Therapeutics Inc. 12 Nov 2025 | | - | - |
| DRMA Dermata Therapeutics Inc. 6 Aug 2025 | | - | - |
| DRMA Dermata Therapeutics Inc. 7 May 2025 | | - | - |
| DRMA Dermata Therapeutics Inc. 15 Nov 2024 | | - | - |
| DRMA Dermata Therapeutics Inc. 15 Aug 2024 | | - | - |
| DRMA Dermata Therapeutics Inc. 16 May 2024 | | - | - |
| DRMA Dermata Therapeutics Inc. 20 Mar 2024 | | - | - |
| DRMA Dermata Therapeutics Inc. 21 Feb 2024 | | - | - |
| DRMA Dermata Therapeutics Inc. 10 Nov 2023 | | - | - |
DRMA Earnings Reports FAQ
What is the earnings per share (EPS) for DRMA?
The current EPS is -1.38.
What is the company's earnings growth rate?
Dermata Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Dermata Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Dermata Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for DRMA at this time, as Dermata Therapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
